JVM Co

JVM Co Rule of 40

The Rule of 40 of JVM Co (054950.KQ) as of Nov 3, 2026 is 27.81 %. In the previous year, Rule of 40 was 20.74 % — a change of 34.12% (higher).

Rule of 40

27.81 %

YoY

34.12%

Last updated:

Rule of 40 of JVM Co is 2025 27.81 % . Rule of 40 of JVM Co was 2024 20.74 % . It decreases by 34.12% higher compared to the previous year.

The JVM Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
6.57 KRW
Jan 1, 2019
11.67 KRW
Jan 1, 2020
15.97 KRW
Jan 1, 2021
10.01 KRW
Jan 1, 2022
36.65 KRW
Jan 1, 2023
29.59 KRW
Jan 1, 2024
20.74 KRW
Jan 1, 2025
27.81 KRW
The JVM Co Rule of 40 history
YEARRule of 40YoY
27.81 %+34.12%
20.74 %-29.93%
29.59 %-19.25%
36.65 %+266.21%
10.01 %-37.32%
15.97 %+36.77%
11.67 %+77.79%
6.57 %-65.91%
19.26 %-16.07%
22.95 %+307.58%
5.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Rule of 40 of JVM Co is 27.81 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 JVM Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — JVM Co

All Key Metrics — JVM Co